GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $17,036,000 | +3.4% | 391,090 | +4.7% | 0.04% | -7.9% |
| Q4 2021 | $16,468,000 | +16.8% | 373,424 | +1.2% | 0.04% | +8.6% |
| Q3 2021 | $14,105,000 | +31.7% | 369,132 | +37.3% | 0.04% | +40.0% |
| Q2 2021 | $10,707,000 | +2.4% | 268,874 | -8.2% | 0.02% | -10.7% |
| Q1 2021 | $10,454,000 | -5.2% | 292,900 | -2.2% | 0.03% | -12.5% |
| Q4 2020 | $11,023,000 | -45.3% | 299,541 | -44.0% | 0.03% | 0.0% |
| Q3 2020 | $20,136,000 | -11.3% | 534,938 | -3.8% | 0.03% | -20.0% |
| Q2 2020 | $22,692,000 | +156.7% | 556,318 | +138.5% | 0.04% | -11.1% |
| Q1 2020 | $8,839,000 | -11.9% | 233,288 | +9.3% | 0.04% | +15.4% |
| Q4 2019 | $10,031,000 | +33.1% | 213,467 | +20.8% | 0.04% | +11.4% |
| Q3 2019 | $7,539,000 | -11.6% | 176,649 | -17.1% | 0.04% | -14.6% |
| Q2 2019 | $8,532,000 | -11.9% | 213,189 | -8.0% | 0.04% | -14.6% |
| Q1 2019 | $9,682,000 | -23.4% | 231,682 | -30.0% | 0.05% | -23.8% |
| Q4 2018 | $12,640,000 | -8.1% | 330,808 | -3.4% | 0.06% | -6.0% |
| Q3 2018 | $13,760,000 | -0.6% | 342,548 | -0.3% | 0.07% | +3.1% |
| Q2 2018 | $13,844,000 | +5.5% | 343,429 | +2.2% | 0.06% | 0.0% |
| Q1 2018 | $13,128,000 | -4.8% | 336,007 | -13.6% | 0.06% | -4.4% |
| Q4 2017 | $13,794,000 | -1.1% | 388,881 | +13.2% | 0.07% | -4.2% |
| Q3 2017 | $13,945,000 | +3.7% | 343,461 | +10.1% | 0.07% | -4.1% |
| Q2 2017 | $13,447,000 | -21.2% | 311,850 | -22.9% | 0.07% | -1.3% |
| Q1 2017 | $17,055,000 | +28.8% | 404,531 | +17.7% | 0.08% | +13.6% |
| Q4 2016 | $13,241,000 | +12.4% | 343,820 | +25.9% | 0.07% | +20.0% |
| Q3 2016 | $11,776,000 | -12.5% | 273,033 | -12.1% | 0.06% | -20.3% |
| Q2 2016 | $13,464,000 | +2.5% | 310,654 | -4.1% | 0.07% | -22.5% |
| Q1 2016 | $13,142,000 | -28.9% | 324,097 | -29.2% | 0.09% | -39.5% |
| Q4 2015 | $18,477,000 | +15.0% | 457,925 | +9.6% | 0.15% | +19.5% |
| Q3 2015 | $16,071,000 | -14.4% | 417,979 | -7.3% | 0.12% | +10.8% |
| Q2 2015 | $18,785,000 | +13.7% | 451,022 | +26.0% | 0.11% | +16.8% |
| Q1 2015 | $16,515,000 | +2.7% | 357,852 | -4.9% | 0.10% | -5.0% |
| Q4 2014 | $16,081,000 | -17.6% | 376,260 | -11.3% | 0.10% | -2.9% |
| Q3 2014 | $19,510,000 | +17.6% | 424,411 | +36.9% | 0.10% | +33.8% |
| Q2 2014 | $16,585,000 | +8.2% | 310,117 | +8.1% | 0.08% | +1.3% |
| Q1 2014 | $15,330,000 | +16.7% | 286,921 | +16.6% | 0.08% | +15.2% |
| Q4 2013 | $13,141,000 | +12.0% | 246,131 | +5.3% | 0.07% | +10.0% |
| Q3 2013 | $11,728,000 | -7.5% | 233,775 | -7.8% | 0.06% | -13.0% |
| Q2 2013 | $12,674,000 | – | 253,630 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |